Filing Signals

Source: SEC EDGAR Compiled 2026-08-23 04:41 UTC Unattended

← All events

60 DEGREES PHARMACEUTICALS, INC.

CIK 1946563 SXTP·Pharmaceutical Preparations · All EDGAR filings ↗

Going concern Filing comparison

60 DEGREES PHARMACEUTICALS, INC. disclosed substantial doubt about its ability to continue as a going concern

Substantial doubt raised, alleviated by management's plans Substantial doubt about ability to continue as a going concern

However, there can be no assurance that it will ever achieve or maintain profitability. Accordingly, there is no assurance that the Company will be able to obtain the additional capital necessary to fund its operations during the look‑forward period. These conditions, among others, raise substantial doubt about the ability of the Company to continue as a going concern for one year from the date these consolidated condensed financial statements are issued. 6 Management plans to fund operations of the Company through third party and related party debt/advances, private placement of restricted se
Evidence
Caveat
None
Comparable
True
Current state
substantial_doubt
Current state label
Substantial doubt about ability to continue as a going concern
Direction
escalated
Located in
going-concern note
Prior filed
2026-05-15
Prior form
10-Q
Prior state
doubt_alleviated
Prior state label
Substantial doubt raised, alleviated by management's plans
Registrant changed from
None
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.